Analysing the advantages of glucagon-like peptide-1 receptor agonists/sodium-glucose cotransporter 2 inhibitors in high vs. low cardiovascular disease risk
3 September 2019 (16:05 - 16:15)
Organised by:
Slides
About the speaker
University College London, London (United Kingdom of Great Britain & Northern Ireland)
3 More presentations in this session
Doctor M. Kosiborod (Kansas City, US)
Doctor B. Scirica (Boston, US)
Doctor M. Kosiborod (Kansas City, US)
Professor J. Deanfield (London, GB)
Doctor B. Scirica (Boston, US)
Access the full session
The Event
ESC Congress 2019
3 September 2019
16:05 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation
